17-19924468-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000225737.11(AKAP10):c.1691C>T(p.Ala564Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000996 in 1,605,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00050 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000058 ( 0 hom. )
Consequence
AKAP10
ENST00000225737.11 missense
ENST00000225737.11 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 5.79
Genes affected
AKAP10 (HGNC:368): (A-kinase anchoring protein 10) This gene encodes a member of the A-kinase anchor protein family. A-kinase anchor proteins bind to the regulatory subunits of protein kinase A (PKA) and confine the holoenzyme to discrete locations within the cell. The encoded protein is localized to mitochondria and interacts with both the type I and type II regulatory subunits of PKA. Polymorphisms in this gene may be associated with increased risk of arrhythmias and sudden cardiac death. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05632931).
BS2
High AC in GnomAd4 at 76 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP10 | NM_007202.4 | c.1691C>T | p.Ala564Val | missense_variant | 11/15 | ENST00000225737.11 | NP_009133.2 | |
AKAP10 | NM_001330152.2 | c.1517C>T | p.Ala506Val | missense_variant | 10/14 | NP_001317081.1 | ||
AKAP10 | XR_007065258.1 | n.1791-4350C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP10 | ENST00000225737.11 | c.1691C>T | p.Ala564Val | missense_variant | 11/15 | 1 | NM_007202.4 | ENSP00000225737.6 | ||
AKAP10 | ENST00000395536.7 | c.1517C>T | p.Ala506Val | missense_variant | 10/14 | 5 | ENSP00000378907.3 |
Frequencies
GnomAD3 genomes AF: 0.000500 AC: 76AN: 152018Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
76
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000891 AC: 22AN: 247038Hom.: 0 AF XY: 0.0000524 AC XY: 7AN XY: 133546
GnomAD3 exomes
AF:
AC:
22
AN:
247038
Hom.:
AF XY:
AC XY:
7
AN XY:
133546
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000578 AC: 84AN: 1453768Hom.: 0 Cov.: 30 AF XY: 0.0000401 AC XY: 29AN XY: 723174
GnomAD4 exome
AF:
AC:
84
AN:
1453768
Hom.:
Cov.:
30
AF XY:
AC XY:
29
AN XY:
723174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000500 AC: 76AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.000512 AC XY: 38AN XY: 74246
GnomAD4 genome
AF:
AC:
76
AN:
152018
Hom.:
Cov.:
32
AF XY:
AC XY:
38
AN XY:
74246
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
13
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.1691C>T (p.A564V) alteration is located in exon 11 (coding exon 11) of the AKAP10 gene. This alteration results from a C to T substitution at nucleotide position 1691, causing the alanine (A) at amino acid position 564 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
D;T
Sift4G
Benign
T;T
Polyphen
D;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at